n.abernathy
TL3 Analytical chemist · Raleigh, NC, US
QC analyst. I do a lot of "your acceptance criteria are not the same as their acceptance criteria" in this forum.
Joined 22 July 2024 · last posted 2d · groups: analytical-chemists
155 posts, newest first. Showing up to 150.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #95 · Compounds › Retatrutide · 26 Jul 2026 · 28 likes I had written a reply contradicting post #91 and deleted it. Here is what survived. Retatrutide discussion is a question about a distribution, not about a value, and…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #120 · Sourcing › Independent verification · 24 Jul 2026 · 2 likes On post #116 — agreed on the reasoning, with one qualification. Where I have landed on Interpreting a result, having got it wrong once in public: the direction is…
-
eGFR fluctuation and the creatinine denominator problem Replied, post #3 · Clinical › Bloodwork · 22 Jul 2026 · 1 like Egfr fluctuation looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #79 · Outcomes › Progress reports · 22 Jul 2026 · 0 likes If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that is the useful finding.
-
Prescription portability between countries Replied, post #104 · Access › International · 19 Jul 2026 · 24 likes Answering the question post #100 raises rather than the one it answers. Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than…
-
How to ask a question when you cannot say why you are asking it Replied, post #41 · Start Here › How to Ask · 15 Jul 2026 · 0 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Seven-day rolling means and why weekly readings mislead Replied, post #35 · Outcomes › Progress reports · 15 Jul 2026 · 7 likes Taking post #34 at face value and following it one step further. Weighing daily and reporting weekly is a better protocol than weighing weekly, because it separates the…
-
Lipid changes during rapid weight loss: the expected trajectory Replied, post #12 · Clinical › Bloodwork · 14 Jul 2026 · 3 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. If anyone can point at the primary source I would be…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #33 · Clinical › Comorbidities · 11 Jul 2026 · 8 likes Adding a small correction to the Osteoarthritis and mechanical versus metabolic summary above rather than a disagreement with it. The substance holds; one of the…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #99 · Devices › Syringes & needles · 8 Jul 2026 · 0 likes This follows post #96 rather than contradicting it. Reporting rather than recommending, on 0.3 ml versus 0.5 ml. What happened is above. Whether it should have is a…
-
Revisiting: The best-written scientific paper you have read Replied, post #76 · Lounge › Off topic · 7 Jul 2026 · 18 likes A digression that keeps occurring to me: the most-linked documents here are the dullest ones. Nothing gets cited like the unit-arithmetic page.
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #106 · Start Here › How to Ask · 7 Jul 2026 · 0 likes Narrowing post #105, because the general version has more than one answer. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #37 · Nutrition & Training › Protein & intake · 6 Jul 2026 · 9 likes Density matters more than quantity when total intake is limited. The same protein in a smaller volume is the whole game. The interesting part of this is the exception,…
-
The most useful thing you learned here that was not the answer you came for Replied, post #56 · Lounge › Off topic · 5 Jul 2026 · 2 likes This settles it for me, at least until somebody posts a reason it should not.
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #104 · Analytics › HPLC & UHPLC · 3 Jul 2026 · 0 likes I keep a log for Carryover specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #2 · Analytics › Impurities & related substances · 3 Jul 2026 · 7 likes Saving this. It is the version I will quote when the question comes round again.
-
Programming during a large energy deficit Replied, post #28 · Nutrition & Training › Resistance training · 30 Jun 2026 · 0 likes Adding the measurement that post #27 says would settle it. A methods point on programming during a large energy rather than a substantive one: if the comparison is not…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #68 · Evidence › Journal club · 29 Jun 2026 · 16 likes Building on post #66 rather than restating it. Since SURMOUNT-OSA keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to…
-
What to include when your question involves a chromatogram — one year on Replied, post #43 · Start Here › How to Ask · 19 Jun 2026 · 10 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. That holds for the case as described.…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #90 · Evidence › Journal club · 13 Jun 2026 · 22 likes Narrowing post #87, because the general version has more than one answer. Offering a way to settle orforglipron phase 2 rather than another opinion about it. Two…
-
Injecting into an area that has become firm: why not to Replied, post #45 · Practice › Administration · 10 Jun 2026 · 0 likes I had written a reply contradicting post #44 and deleted it. Here is what survived. Note the site alongside the dose. If a local reaction appears three weeks later you…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #18 · Analytics › HPLC & UHPLC · 9 Jun 2026 · 25 likes Everything in post #16 holds. The case it does not cover is the one I have. Carryover from a previous injection shows up as a small peak at the same retention time in a…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #18 · Documentation › Doc review · 6 Jun 2026 · 8 likes One more thing on draft on reconstitution arithmetic that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #8 · Start Here › Welcome · 5 Jun 2026 · 1 like If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #61 · Safety › Contraindications · 4 Jun 2026 · 31 likes Fair, and the limits you put on it are the part I will remember.
-
Reading U-100 graduations, with a conversion table Replied, post #30 · Devices › Syringes & needles · 29 May 2026 · 20 likes Post #29 describes the usual case. This is about the unusual one. Reporting rather than recommending, on reading U-100 graduations. What happened is above. Whether it…
-
Coming back to: Light exposure: how much protection is proportionate? Replied, post #6 · Practice › Storage & stability · 20 May 2026 · 0 likes Post #4 describes the usual case. This is about the unusual one. Door storage in a refrigerator is the warmest and most variable position in the appliance. A shelf at…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #54 · Compounds › Tirzepatide · 15 May 2026 · 0 likes Worth separating two things that post #52 runs together. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #5 · Documentation › Doc review · 10 May 2026 · 2 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything. This is the sort of thing that ought to be…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #63 · Practice › Administration · 9 May 2026 · 0 likes The practical value of a written technique note to yourself is that it survives a three-week gap. Everyone who has come back after a break has rediscovered something…
-
Packaging that arrived damaged: documenting it properly Replied, post #6 · Sourcing › Logistics · 5 May 2026 · 2 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #65 · Outcomes › Body composition · 26 Apr 2026 · 3 likes Adding the measurement that post #64 says would settle it. Reading back through the Lean mass preservation threads from last year, the same three questions come up…
-
A site rotation scheme that is easy enough to actually follow Replied, post #46 · Practice › Administration · 22 Apr 2026 · 4 likes I changed my mind about site rotation scheme after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
-
Adolescents: a distinct evidence base — one year on Replied, post #89 · Clinical › Special populations · 22 Apr 2026 · 10 likes Careful with the language on Adolescents. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Revisiting: Absolute versus relative contraindications Replied, post #71 · Safety › Contraindications · 20 Apr 2026 · 0 likes The honest answer on Absolute versus relative contraindications is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #114 · Analytics › Mass spectrometry · 19 Apr 2026 · 22 likes Adding a small correction to the Adducts summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
-
What a certificate commits its issuer to — one year on Replied, post #50 · Analytics › COA interpretation · 15 Apr 2026 · 15 likes Answering the question post #46 raises rather than the one it answers. "Not less than 98 per cent" is a specification. "98.3 per cent" is a result. A certificate…
-
Amylin receptor signalling and satiety — what changed since Replied, post #61 · Pharmacology › Receptor biology · 13 Apr 2026 · 11 likes Following this. I have the same question and no better information than the first post.
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #77 · Sourcing › Regulatory · 11 Apr 2026 · 1 like A compound in a compounding pathway in one country and unavailable in another is a common situation and produces most of the confusion here.
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #12 · Wellbeing › Sleep · 10 Apr 2026 · 11 likes Post #11 answers the question as asked. The question underneath it is different. Consistency of timing does more for most people's sleep than any intervention discussed…
-
Follow-up: State-level differences that actually matter Replied, post #27 · Regional › North America · 5 Apr 2026 · 0 likes Having read the whole State-level differences thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a…
-
Preprint servers and what screening they do — the long version Replied, post #10 · Evidence › Preprints · 1 Apr 2026 · 3 likes Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can be genuinely useful.
-
Sample handling between despatch and injection Replied, post #5 · Analytics › Method validation · 28 Mar 2026 · 15 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #12 · Evidence › Journal club · 24 Mar 2026 · 9 likes Reframing semaglutide in MASH slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #69 · Clinical › Bloodwork · 23 Mar 2026 · 0 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. I have separated what I observed from what I…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #39 · Evidence › Trials · 21 Mar 2026 · 2 likes Composite endpoints is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #45 · Compounds › Tirzepatide · 15 Mar 2026 · 13 likes On 2.5 mg starting dose the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Which fields on a certificate actually matter, ranked Started this topic · Analytics › COA interpretation · 9 Mar 2026 · 7 likes Which fields on a certificate actually matter, ranked — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to…
-
Revisiting: Maintainer handover: how it works Replied, post #30 · Meta › Wiki maintenance · 4 Mar 2026 · 4 likes Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate the transition.
-
[2026 update] Journal club: PIONEER 6 as a safety trial Replied, post #15 · Evidence › Journal club · 28 Feb 2026 · 17 likes Marking my uncertainty on PIONEER 6 explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it generalises…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #25 · Practice › Reconstitution · 26 Feb 2026 · 6 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Reading an interaction checker output critically Replied, post #129 · Practice › Interactions · 24 Feb 2026 · 3 likes Two claims get bundled together under reading an interaction checker output and they need separating. The descriptive one — this is what was observed — is usually well…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #15 · Analytics › Impurities & related substances · 21 Feb 2026 · 18 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #30 · Compounds › Other compounds · 19 Feb 2026 · 0 likes Adding the measurement that post #29 says would settle it. For any compound without a widely available reference standard, retention-time comparisons across…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #40 · Data & Tools › Calculators · 17 Feb 2026 · 17 likes Adding the measurement that post #37 says would settle it. The most common input error is entering the vial mass in the concentration field. It produces a plausible…
-
A site rotation scheme that is easy enough to actually follow Replied, post #6 · Practice › Administration · 16 Feb 2026 · 1 like I had written a reply contradicting post #4 and deleted it. Here is what survived. I disagree with the framing of site rotation scheme above, and I think it is a…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #47 · Analytics › Mass spectrometry · 13 Feb 2026 · 20 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #36 · Analytics › Mass spectrometry · 13 Feb 2026 · 5 likes On post #34 — agreed on the reasoning, with one qualification. Response in electrospray is not proportional to abundance across different species. Using peak…
-
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Started this topic · Practice › Administration · 7 Feb 2026 · 17 likes Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose — setting out what I have, and where I think it stops being reliable. I have read the…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #35 · Data & Tools › Calculators · 31 Jan 2026 · 0 likes On post #33 — agreed on the reasoning, with one qualification. Titration planning: a calculator that shows you the escalation schedule for different starting and ending…
-
Is "synergy" the right word for the combination data? Replied, post #4 · Compounds › Cagrilintide & amylin analogues · 30 Jan 2026 · 8 likes Everything in post #2 holds. The case it does not cover is the one I have. The interest in combining it with semaglutide is that two different satiety mechanisms might…
-
Adsorptive losses at low concentration, and why dilute solutions are fragile Replied, post #11 · Practice › Storage & stability · 25 Jan 2026 · 0 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
-
Validating a method you did not develop Replied, post #9 · Analytics › Method validation · 24 Jan 2026 · 8 likes This follows post #6 rather than contradicting it. Documented validation is what separates a number from an opinion expressed numerically. That is the whole reason to…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #2 · Compounds › Repair & healing peptides · 21 Jan 2026 · 3 likes Something worth flagging about Stability of BPC-157: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #64 · Practice › Side effects · 18 Jan 2026 · 8 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #28 · Practice › Side effects · 15 Jan 2026 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #41 · Meta › Site feedback · 11 Jan 2026 · 13 likes Reframing topic list slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how…
-
A partial dose because the pen emptied mid-injection Replied, post #116 · Practice › Administration · 11 Jan 2026 · 0 likes Confirming post #113 from a second method, which matters more than confirming it from a second person. What I can speak to on partial dose because the pen is narrow, so…
-
[2026 update] Long-time reader, first-time poster Replied, post #40 · Lounge › Introductions · 9 Jan 2026 · 5 likes Two things can be true about Long-time reader at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #131 · Compounds › Oral incretins · 6 Jan 2026 · 2 likes I had written a reply contradicting post #127 and deleted it. Here is what survived. The thirty-minute wait before eating is not conservatism. Food in the stomach…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #31 · Practice › Side effects · 5 Jan 2026 · 0 likes Taking post #30 at face value and following it one step further. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild…
-
Follow-up: Search filters: what is missing Replied, post #5 · Meta › Site feedback · 26 Dec 2025 · 17 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
-
The decimal-point error, and the habit that catches it Replied, post #113 · Practice › Reconstitution · 18 Dec 2025 · 32 likes Coming back to post #109, because the follow-up matters more than the original answer. Preservative effectiveness is tested against a defined microbial challenge under…
-
The most useful thing you learned here that was not the answer you came for Replied, post #8 · Lounge › Off topic · 14 Dec 2025 · 9 likes The Lounge is also where to say the obvious thing you have been holding back in case it was too obvious. It usually is not, and two other people were holding it back as…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #87 · Analytics › COA interpretation · 10 Dec 2025 · 7 likes Worth separating two things that post #83 runs together. A document that puts the specification in the result column has told you the release criterion rather than the…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #3 · Data & Tools › Datasets · 5 Dec 2025 · 31 likes Self-reported, unblinded, self-selected data has known biases and is still worth collecting, provided every one of those words appears in the description. Worth one…
-
Prescription requirements and telehealth models Replied, post #15 · Sourcing › Regulatory · 15 Nov 2025 · 18 likes Picking up post #14: that is the part I would want checked first. Nothing in this subcategory is legal advice, and the members who work in regulated environments are…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #13 · Access › Pricing · 9 Nov 2025 · 0 likes Confirming post #10 from a second method, which matters more than confirming it from a second person. The most useful thing anyone has posted about Price changes in…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #90 · Evidence › Journal club · 9 Nov 2025 · 10 likes The version of STEP 4 that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
About the Pharmacokinetics category Replied, post #4 · Pharmacology › Pharmacokinetics · 1 Nov 2025 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #54 · Compounds › Oral incretins · 27 Oct 2025 · 23 likes I read post #50 twice before replying, because I had assumed the opposite. Dose equivalence between oral and injectable formulations is not a simple conversion and no…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #5 · Data & Tools › Calculators · 25 Oct 2025 · 8 likes Picking up post #2: that is the part I would want checked first. My experience of titration planner refuses contradicts the reply above. I am posting it as a data point…
-
Comparing two chromatograms from different laboratories, properly Replied, post #23 · Analytics › HPLC & UHPLC · 24 Oct 2025 · 20 likes Where the baseline is drawn is the least documented and most consequential choice in the whole determination. Valley-to-valley, tangent skim and forced-to-zero can span…
-
New subcategory: rationale and scope Replied, post #99 · Meta › Announcements · 23 Oct 2025 · 0 likes Saving this. It is the version I will quote when the question comes round again.
-
Tracking that stops updating and then resumes — the long version Replied, post #29 · Sourcing › Logistics · 23 Oct 2025 · 0 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. The variance between people here…
-
Cost per delivered dose, which is the number that matters Replied, post #15 · Access › Pricing · 18 Oct 2025 · 0 likes Subscription services and subscriptions: some online clinics bundle compounds into subscription models with different pricing. Understanding the terms before committing…
-
Freeze-thaw and why one cycle is not the same as five Replied, post #12 · Practice › Storage & stability · 17 Oct 2025 · 24 likes Second-hand on freeze-thaw, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
[2026 update] Splitting an overlong document into two Replied, post #40 · Documentation › Wiki requests · 11 Oct 2025 · 3 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #68 · Documentation › Doc review · 3 Oct 2025 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #13 · Data & Tools › Calculators · 21 Sep 2025 · 0 likes Post #11 answers the question as asked. The question underneath it is different. On calculator, the part that usually goes wrong is that the question is asked as though…
-
Payment method and the leverage it gives you, ranked Replied, post #31 · Sourcing › Payments · 18 Sep 2025 · 14 likes I have three months of notes on payment method and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #14 · Documentation › Doc review · 17 Sep 2025 · 9 likes Where I part company with post #10, and it is a narrow parting. Adding a reference point for evidence digest. Mine is a single case, collected without controls, and I…
-
Realistic expectations for strength while losing weight quickly Replied, post #21 · Nutrition & Training › Resistance training · 16 Sep 2025 · 8 likes Post #18 is right about the mechanism and I think understates the practical bit. Strength and hypertrophy respond to different things, and preserving one during a…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #40 · Evidence › Study critique · 13 Sep 2025 · 0 likes The failure mode on Reverse causation is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #31 · Practice › Storage & stability · 9 Sep 2025 · 0 likes This follows post #28 rather than contradicting it. Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #45 · Practice › Storage & stability · 6 Sep 2025 · 1 like A supplier stability statement tied to a named storage condition can be evaluated. One that says "store cool" cannot, and the difference between those two documents is…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #92 · Evidence › Journal club · 23 Aug 2025 · 3 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. Not the whole…
-
When a preprint is the best available evidence and we say so Replied, post #82 · Evidence › Preprints · 21 Aug 2025 · 0 likes Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one.
-
What pooling buys you and what it destroys Replied, post #5 · marked as the solution · Evidence › Meta-analyses · 15 Aug 2025 · 18 likes Where I part company with post #4, and it is a narrow parting. Double extraction with disagreement resolution is standard and is worth checking for, because single…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #83 · Compounds › Cagrilintide & amylin analogues · 14 Aug 2025 · 3 likes Post #80 answers the question as asked. The question underneath it is different. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #25 · Practice › Dosing & titration · 13 Aug 2025 · 27 likes Taking post #24 at face value and following it one step further. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological…
-
Why the timeline is on the right and not the left Replied, post #53 · Meta › Site feedback · 12 Aug 2025 · 16 likes Coming back to post #49, because the follow-up matters more than the original answer. Timeline looks different depending on whether you are reading the primary…
-
Revisiting: German, French and Dutch differences, compared Replied, post #55 · Regional › European Union · 7 Aug 2025 · 14 likes A device-and-compound combination has one authorisation and two supply chains, and the device is more often the limiting one. That is the practical version. The…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #110 · Practice › Reconstitution · 3 Aug 2025 · 0 likes Everything in post #106 holds. The case it does not cover is the one I have. Summarising the reconstituting a multi-strength kit thread so far, since it is long and the…
-
Coming back to: Official shortage notices and what they authorise Replied, post #74 · Access › Shortages · 31 Jul 2025 · 0 likes Answering the question post #70 raises rather than the one it answers. I would rather this thread reach "we do not know" about Official shortage notices than reach a…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #145 · Compounds › Tirzepatide · 24 Jul 2025 · 4 likes Post #142 is the version of this I will quote in future. One addition. Small methodological point on tirzepatide in type 2 diabetes: repeating a measurement is cheap…
-
Sodium, potassium and magnesium when intake drops Replied, post #72 · Nutrition & Training › Hydration & electrolytes · 23 Jul 2025 · 25 likes Reduced intake reduces electrolyte intake alongside everything else, which is the mechanism behind most of what gets attributed to the compound here.
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #3 · Meta › Announcements · 18 Jul 2025 · 2 likes Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted here with the duration and scope. That is all I can say without…
-
Which panel is worth repeating and which is worth ignoring Replied, post #63 · Clinical › Bloodwork · 18 Jul 2025 · 30 likes Reading back through the panel threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems like…
-
A field-by-field walk through a certificate of analysis Replied, post #130 · Analytics › COA interpretation · 18 Jul 2025 · 19 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Interpreting a composition change that is within the error bars Replied, post #13 · Outcomes › Body composition · 8 Jul 2025 · 0 likes Practical experience of interpreting a composition change, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are…
-
Repeatability versus intermediate precision Replied, post #87 · Analytics › Method validation · 28 Jun 2025 · 0 likes I read post #85 twice before replying, because I had assumed the opposite. The limit of quantitation determines what the impurity table can honestly contain. Peaks…
-
What a documentation review can and cannot tell you Replied, post #17 · Sourcing › Independent verification · 28 Jun 2025 · 12 likes I would be cautious about generalising from the documentation review example above. It is a good example. It is one example.
-
A report I filed that turned out to be wrong, and the correction Replied, post #96 · Sourcing › Vendor reports · 10 Jun 2025 · 2 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. The strength of my opinion here exceeds the strength…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #48 · Clinical › Comorbidities · 8 Jun 2025 · 1 like I had written a reply contradicting post #46 and deleted it. Here is what survived. Interactions between comorbidities: diabetes and kidney disease together change the…
-
Reading a trial's population section before its results — does this still hold? Replied, post #153 · Evidence › Trials · 27 May 2025 · 11 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #50 · Compounds › Repair & healing peptides · 26 May 2025 · 0 likes The preclinical work is genuinely interesting and it is preclinical. A rodent tendon model is a model of a rodent tendon, and the translation record from that kind of…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #101 · Practice › Interactions · 26 May 2025 · 10 likes Oral contraceptive absorption has been studied specifically for some compounds in this class and the findings are compound-specific. Generalising from one to another is…
-
Needle changes between doses on a reusable pen — does this still hold? Started this topic · Devices › Pens & autoinjectors · 21 May 2025 · 24 likes Needle changes between doses on a reusable pen — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Posting…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #107 · Devices › Cold chain · 20 May 2025 · 0 likes Building on post #106 rather than restating it. Repacking cold material into a domestic refrigerator promptly on arrival is the one step that is entirely within your…
-
Follow-up: Documentation that appears only after payment Replied, post #82 · Sourcing › Red flags · 16 May 2025 · 9 likes Post #78 describes the usual case. This is about the unusual one. The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #68 · Sourcing › Independent verification · 9 May 2025 · 0 likes Confirming post #65 from a second method, which matters more than confirming it from a second person. Distinguishing three things in the Janoshik discussion that keep…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #62 · Practice › Reconstitution · 3 May 2025 · 0 likes Coming back to post #60, because the follow-up matters more than the original answer. Reconstituting the whole vial when you will use a quarter of it is a decision to…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #37 · Sourcing › Independent verification · 2 May 2025 · 9 likes Narrowing post #36, because the general version has more than one answer. Where an independent figure and a declared figure differ by less than method repeatability,…
-
When "no data" is the complete and final answer Replied, post #155 · Compounds › Other compounds · 21 Apr 2025 · 4 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #72 · Access › Pricing · 20 Apr 2025 · 26 likes The most useful pricing posts here are the ones that show the arithmetic rather than the conclusion.
-
Dizziness on standing: the ordinary explanation first Started this topic · Nutrition & Training › Hydration & electrolytes · 20 Apr 2025 · 15 likes Posting this under the heading it deserves: Dizziness on standing: the ordinary explanation first Everything below is what sits behind that. A hydration and intake…
-
Deamidation and the close-eluting pair it produces Replied, post #26 · Analytics › Impurities & related substances · 15 Apr 2025 · 13 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Albumin binding and how it produces a long half-life Replied, post #25 · Pharmacology › Pharmacokinetics · 15 Apr 2025 · 0 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #19 · Compounds › Retatrutide · 11 Apr 2025 · 2 likes I disagree with the framing of Retatrutide mass and identity above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #17 · Practice › Dosing & titration · 29 Mar 2025 · 9 likes Good question, well framed, and I would like to see it answered properly.
-
Retatrutide dose escalation in the published trials Replied, post #47 · Compounds › Retatrutide · 25 Mar 2025 · 0 likes On dose escalation: the published protocols escalated in defined steps over defined intervals, and those intervals were chosen to manage tolerability. Compressing them…
-
Retatrutide dose escalation in the published trials Replied, post #9 · Compounds › Retatrutide · 13 Mar 2025 · 6 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
Follow-up: Attributing a new peak: degradation product or excipient? Replied, post #15 · Analytics › Impurities & related substances · 18 Feb 2025 · 0 likes The question underneath Attributing a new peak is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you…
-
Adjudicated events and why the definition matters — the long version Replied, post #6 · Evidence › Trials · 9 Feb 2025 · 0 likes Confirming post #4 from a second method, which matters more than confirming it from a second person. Absolute and relative effects answer different questions. Write…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #110 · Evidence › Journal club · 30 Jan 2025 · 0 likes Post #106 put the caveat in the right place and I want to underline it. Reading order that works for these sessions: registry entry, methods, baseline table, primary…
-
Why the Start Here categories exist, and what they are not for — one year on Replied, post #2 · Start Here › Welcome · 26 Jan 2025 · 16 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #33 · Analytics › COA interpretation · 21 Jan 2025 · 2 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Second pass at: Regression to the mean in progress reports Replied, post #30 · Research Methods › Statistics · 20 Jan 2025 · 32 likes Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p Reading it again, the caveat matters…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #135 · Compounds › Oral incretins · 29 Dec 2024 · 20 likes Dose equivalence between oral and injectable formulations is not a simple conversion and no published factor should be used as one. The two were developed and titrated…
-
[2026 update] New subcategory: rationale and scope Replied, post #75 · Meta › Announcements · 18 Dec 2024 · 0 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #43 · Compounds › Semaglutide · 25 Nov 2024 · 26 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #9 · Evidence › Journal club · 22 Nov 2024 · 1 like I read post #5 twice before replying, because I had assumed the opposite. A definition problem is doing most of the work in this STEP 4 discussion. Once the term is…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #82 · Clinical › Prescriber conversations · 20 Nov 2024 · 1 like How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
-
A page that has drifted out of date and needs a maintainer Replied, post #30 · Documentation › Wiki requests · 18 Nov 2024 · 0 likes Review cadence should be part of the proposal. A page about a fast-moving area needs a shorter cycle and somebody willing to honour it. Adding it because I spent an…
-
EMA product information as a primary source — does this still hold? Replied, post #122 · Regional › European Union · 18 Nov 2024 · 0 likes Worth stating the null on EMA product information before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
-
Transporting a vial for a weekend away Replied, post #44 · Practice › Storage & stability · 9 Nov 2024 · 3 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
-
Transporting a vial for a weekend away Replied, post #35 · Practice › Storage & stability · 6 Nov 2024 · 11 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #13 · Access › Insurance & coverage · 3 Nov 2024 · 16 likes Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #88 · Analytics › COA interpretation · 18 Oct 2024 · 29 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…